NM_000044.6:c.1415_1420delGCGGCG

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000044.6(AR):​c.1415_1420delGCGGCG​(p.Gly472_Gly473del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0114 in 557,735 control chromosomes in the GnomAD database, including 418 homozygotes. There are 1,145 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G472G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.036 ( 169 hom., 408 hem., cov: 0)
Exomes 𝑓: 0.0070 ( 249 hom. 737 hem. )

Consequence

AR
NM_000044.6 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.29

Publications

6 publications found
Variant links:
Genes affected
AR (HGNC:644): (androgen receptor) The androgen receptor gene is more than 90 kb long and codes for a protein that has 3 major functional domains: the N-terminal domain, DNA-binding domain, and androgen-binding domain. The protein functions as a steroid-hormone activated transcription factor. Upon binding the hormone ligand, the receptor dissociates from accessory proteins, translocates into the nucleus, dimerizes, and then stimulates transcription of androgen responsive genes. This gene contains 2 polymorphic trinucleotide repeat segments that encode polyglutamine and polyglycine tracts in the N-terminal transactivation domain of its protein. Expansion of the polyglutamine tract from the normal 9-34 repeats to the pathogenic 38-62 repeats causes spinal bulbar muscular atrophy (SBMA, also known as Kennedy's disease). Mutations in this gene are also associated with complete androgen insensitivity (CAIS). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2017]
AR Gene-Disease associations (from GenCC):
  • androgen insensitivity syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
  • Kennedy disease
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • partial androgen insensitivity syndrome
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • complete androgen insensitivity syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant X-67546514-TGGCGGC-T is Benign according to our data. Variant chrX-67546514-TGGCGGC-T is described in ClinVar as [Likely_benign]. Clinvar id is 434260.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARNM_000044.6 linkc.1415_1420delGCGGCG p.Gly472_Gly473del disruptive_inframe_deletion Exon 1 of 8 ENST00000374690.9 NP_000035.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARENST00000374690.9 linkc.1415_1420delGCGGCG p.Gly472_Gly473del disruptive_inframe_deletion Exon 1 of 8 1 NM_000044.6 ENSP00000363822.3 P10275-1

Frequencies

GnomAD3 genomes
AF:
0.0363
AC:
3014
AN:
83027
Hom.:
169
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0138
Gnomad ASJ
AF:
0.000450
Gnomad EAS
AF:
0.00505
Gnomad SAS
AF:
0.00720
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00513
Gnomad NFE
AF:
0.00253
Gnomad OTH
AF:
0.0255
GnomAD4 exome
AF:
0.00700
AC:
3325
AN:
474704
Hom.:
249
AF XY:
0.00628
AC XY:
737
AN XY:
117274
show subpopulations
African (AFR)
AF:
0.122
AC:
1572
AN:
12914
American (AMR)
AF:
0.00596
AC:
51
AN:
8560
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
11
AN:
9542
East Asian (EAS)
AF:
0.00695
AC:
97
AN:
13950
South Asian (SAS)
AF:
0.00743
AC:
109
AN:
14679
European-Finnish (FIN)
AF:
0.00212
AC:
46
AN:
21679
Middle Eastern (MID)
AF:
0.0177
AC:
23
AN:
1299
European-Non Finnish (NFE)
AF:
0.00298
AC:
1106
AN:
371590
Other (OTH)
AF:
0.0151
AC:
310
AN:
20491
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
64
127
191
254
318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0364
AC:
3019
AN:
83031
Hom.:
169
Cov.:
0
AF XY:
0.0245
AC XY:
408
AN XY:
16621
show subpopulations
African (AFR)
AF:
0.127
AC:
2748
AN:
21625
American (AMR)
AF:
0.0139
AC:
109
AN:
7817
Ashkenazi Jewish (ASJ)
AF:
0.000450
AC:
1
AN:
2222
East Asian (EAS)
AF:
0.00507
AC:
13
AN:
2564
South Asian (SAS)
AF:
0.00723
AC:
11
AN:
1522
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2382
Middle Eastern (MID)
AF:
0.00575
AC:
1
AN:
174
European-Non Finnish (NFE)
AF:
0.00253
AC:
109
AN:
43136
Other (OTH)
AF:
0.0251
AC:
27
AN:
1076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
94
188
283
377
471
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
327

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Sep 26, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Androgen resistance syndrome;C1839259:Kennedy disease Benign:1
Sep 13, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 12, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

AR-related disorder Benign:1
Sep 09, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.3
Mutation Taster
=197/3
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746853821; hg19: chrX-66766356; COSMIC: COSV105928512; API